273 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – record date Conformément aux dispositions des articles L233-8-II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers |
24/05/2023 | Shareholders´s Meeting | |
Q1 2023 Sales: €145M Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates. |
20/04/2023 | Public releases | |
BALO : Avis de convocation / avis de réunion Mesdames et Messieurs les actionnaires sont convoqués le jeudi 25 mai 2023 à 11h00 au siège social, Magny-Vernois 70200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions ci-après. |
14/04/2023 | Shareholders´s Meeting | |
Availability of the 2022 universal registration document On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
13/04/2023 | Public releases | |
2022 ANNUAL RESULTS Annual sales: €540m (up 3.6% as reported) |
23/03/2023 | Public releases | |
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
18/01/2023 | Public releases | |
First nine months 2022 sales: €405M In line with year-end outlook |
12/10/2022 | Public releases | |
2022 HALF YEAR RESULTS Additional information on the Group’s strategy Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook. |
23/09/2022 | Public releases , Half Year Report | |
2022 HALF YEAR RESULTS Sales: €271m (up 6.0% as reported) |
15/09/2022 | Public releases | |
H1 2022 Sales H1 2022 Sales: €271m, up 6.1% |
20/07/2022 | Public releases |